Hims Super Bowl ad downplays risks of compounded drugs

Hims & Hers Hopes Super Bowl Commercial About Obesity Stands Apart From Pack of Snacks
Hims & Hers, a tele-health start-up, aims to stand apart from dozens of Super Bowl commercials hawking snacks with a spot that discusses obesity
Hims & Hers to Advertise Weight-Loss Shots at the Super Bowl
Telehealth provider will make its big game debut as the semaglutide shortage continues to sustain the firm’s lower-priced injectables.
‘Incredibly irresponsible’: Hims Super Bowl ad downplays risks of compounded drugs
A multi-million dollar Super Bowl ad from telehealth company Hims and Hers downplays risks and side effects of compounded weight loss drugs.
Hims & Hers to air its first Super Bowl spot, promoting weight loss drugs
The Super Bowl spot is part of a larger campaign as Hims & Hers continues to highlight its weight loss treatments. The ad will air after Feb. 9 in 30-, 15- and 6-second versions on both broadcast and digital channels. The brand worked with Tinuiti on media duties.
Hims & Hers is making a big bet on a Super Bowl ad
The millennial-targeted telehealth company Hims & Hers (HIMS) is spending big bucks on its first ever Super Bowl commercial to hawk its affordable weight-loss treatments.
Thinner Amid Gluttony? Hims & Hers Debut First SB Ads For Weight-Loss Drugs
Telehealth company's spot decries medications from others as "priced for profits, not patients," while its own weight-loss drugs are "affordable."
HIMS stock soars to all-time high, reaching $35.07
In a remarkable display of market confidence, HIMS & Hers Health, Inc. (HIMS) stock has soared to an all-time high, reaching ...
Money Morning1h
HIMS Shares Seeing Buy the Rumor Rally, This is Their Target
Today’s rally breaks the stock into new-high territory in a clear move by investors to start buying HIM stock ahead of its next quarterly report on March 3. The move is also being fueled by a positive ...
Hims & Hers: Potential Risks Ahead, But Shorting May Be Premature
Hims & Hers may leverage FDA compounding exemptions to further extend its compounded GLP-1 offerings. Learn why HIMS stock is ...
Game day prep: 22 tailgate slow cooker dishes ranked from healthiest to unhealthiest
Hims evaluates the nutrition of easy-prep slow cooker recipes designed to get your tailgate party off to a fun and healthy ...
STAT1d
RFK Jr.’s confirmation hearings, MASH drugs, and a controversial obesity ad
Why have drugs to treat the liver disease MASH reached a tipping point? How did Hims & Hers convince Childish Gambino to ...
Hims & Hers: Ready To Outperform Further
Discover why Hims & Hers Health is a top telehealth leader with impressive growth potential and a promising future for ...
Zacks.com on MSN1d
Hims & Hers Stock Surges 69.2% in Three Months: What's Next?
Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term gains from the stock of late. Shares of the ...
STAT1d
What models flourished in the first generation of health tech?
AI in drug development is a vague term that might mean many things, and today, Owkin is announcing it has enrolled the first patient in a phase 1 study of OKN4395, its “AI-optimized” candidate for ...